Acacia Pharma
Indianapolis, US · 2 known investors
Find your way into Acacia Pharma
Sign up to see every warm intro you have to Acacia Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Acacia Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Eagle Pharmaceuticals develops and commercializes specialty pharmaceutical products for acute care and oncology, including injectable medications for procedural sedation, chemotherapy, lymphomas, and malignant hyperthermia management.
Investors · 2
F-Prime Capitallisted by F-Prime CapitalCambridge · $3M – $10M
How we know: F-Prime Capital's portfolio page · a partner's Signal profile · Not right? Tell us
Gilde HealthcarereportedUtrecht · $1.1M – $55M
How we know: funding news · gildehealthcare.com · Not right? Tell us
Frequently asked questions
- What does Acacia Pharma do?
- Eagle Pharmaceuticals develops and commercializes specialty pharmaceutical products for acute care and oncology, including injectable medications for procedural sedation, chemotherapy, lymphomas, and malignant hyperthermia management.
- Who are Acacia Pharma's investors?
- Acacia Pharma's investors include F-Prime Capital, Gilde Healthcare.
- Where is Acacia Pharma headquartered?
- Acacia Pharma is headquartered in Indianapolis, US.